SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-21-002776
Filing Date
2021-04-26
Accepted
2021-04-26 19:52:40
Documents
1
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4372
  Complete submission text file 0001171843-21-002776.txt   5816
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Issuer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 14 CAMBRIDGE CENTER, BLDG 1 CAMBRIDGE MA 02142
Business Address
Csimma Cristina (Reporting) CIK: 0001501623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 21855516